16:37 EDT Eton Pharmaceuticals (ETON) sees reaching annual revenue run rate of $80M in Q3
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ETON:
- Eton Pharmaceuticals’ ET-600 Launch and Strategic Expansion Drive Buy Rating
- Eton Pharmaceuticals’ New Drug Application Accepted by FDA
- Eton Pharmaceuticals’ NDA for ET-600 solution accepted by FDA
- Eton Pharmaceuticals management to meet with B. Riley
- Eton Pharmaceuticals Joins Russell 3000 and 2000 Indexes